Artificial Intelligence in Gastrointestinal Endoscopy: The Japan Gastroenterological Endoscopy Society Position Statements

Research and development of artificial intelligence (AI) in the field of gastrointestinal endoscopy is progressing rapidly. In Japan alone, there are more than 10 AI-assisted endoscopic medical devices that have received regulatory approval, and numerous randomized controlled trials have been published both domestically and internationally. However, the adoption of AI in clinical practice has not been smooth due to factors such as insufficient evaluation of the balance between clinical benefits and harms, unclear cost-effectiveness, the lack of reliable guidelines, and the absence of established reimbursement systems for medical fees. Considering this situation, the Japan Gastroenterological Endoscopy Society (JGES) presents its perspective on the status of AI in endoscopic practice in the form of the following position statements. This comprises nine statements developed by the JGES AI Committee in collaboration with a diverse panel of members. These statements comprehensively address issues related to the quality of endoscopic examinations, cost-effectiveness, clinical disadvantages, preparatory knowledge, medical safety, and legal responsibilities. They have been developed to be practical and useful in actual endoscopy settings.

Authors

Institutions

Publication Details

Journal
Digestive Endoscopy
Published
2025-06-30
DOI
https://doi.org/10.1111/den.15075
Citations
4
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
4.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Intelligence in Gastrointestinal Endoscopy: The Japan Gastroenterological Endoscopy Society Position Statements

Maasa Sasabe, Misaki Ishiyama, Yohei Yabuuchi, Motohiko Kato et al.
4 citations
Digestive Endoscopy
Colorectal Cancer Screening and Detection
4.18
article

Artificial Intelligence in Gastrointestinal Endoscopy: The Japan Gastroenterological Endoscopy Society Position Statements

Maasa Sasabe, Misaki Ishiyama, Yohei Yabuuchi, Motohiko Kato, Masami Omae, Masayoshi Yamada, Yasushi Oda, Ryu Ishihara, Koji Matsuda, Tomonori Yano, Daisuke Yamaguchi, Mai Ego, Yutaka Saito, Akiko Shiotani, Masashi Misawa, Yoshinori Igarashi, Takuto Hikichi, Mitsuhiro Fujishiro, Haruhiko Ogata, Masau Sekiguchi, Taku Sakamoto, Kazuki Sumiyama, Rika Aoki, Atsushi Imagawa, Toshiaki Hirasawa, Hiromu Kutsumi, Naoto Tamai, Shinji Tanaka, Shiho Suzuki, Hisao Tajiri, Yuichi Mori
article en
4 citations

Abstract

Research and development of artificial intelligence (AI) in the field of gastrointestinal endoscopy is progressing rapidly. In Japan alone, there are more than 10 AI-assisted endoscopic medical devices that have received regulatory approval, and numerous randomized controlled trials have been published both domestically and internationally. However, the adoption of AI in clinical practice has not been smooth due to factors such as insufficient evaluation of the balance between clinical benefits and harms, unclear cost-effectiveness, the lack of reliable guidelines, and the absence of established reimbursement systems for medical fees. Considering this situation, the Japan Gastroenterological Endoscopy Society (JGES) presents its perspective on the status of AI in endoscopic practice in the form of the following position statements. This comprises nine statements developed by the JGES AI Committee in collaboration with a diverse panel of members. These statements comprehensively address issues related to the quality of endoscopic examinations, cost-effectiveness, clinical disadvantages, preparatory knowledge, medical safety, and legal responsibilities. They have been developed to be practical and useful in actual endoscopy settings.

Digestive EndoscopyVol. 37(10)
Jikei University School of Medicine (JP), Oslo University Hospital (NO), Toho University (JP), Karolinska University Hospital (SE), Fujita Health University (JP), University of Tsukuba (JP), Saga University (JP), University of Oslo (NO), Kawasaki Medical School (JP), Keio University (JP), Karolinska Institutet (SE), Toho University Omori Medical Center (JP), Mito Saiseikai General Hospital (JP), SHOWA Medical University Northern Yokohama Hospital (JP), Akashi Municipal City Hospital (JP), Saitama Cancer Center (JP), Shizuoka Medical Center (JP), The Cancer Institute Hospital (JP), National Cancer Center Hospital East (JP), Fukushima Medical University Hospital (JP), Edogawa Hospital (JP), Osaka International Cancer Institute (JP), Kobe City Medical Center General Hospital (JP), Onomichi General Hospital (JP), The University of Tokyo (JP)
Partnerships for the goals
Openalex Percentile: Top 5%
Colorectal Cancer Screening and Detection
4.18
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.